Cogent Biosciences (COGT) Change in Receivables (2017 - 2020)

Cogent Biosciences' Change in Receivables history runs 4 years deep, the most recent figure standing at -$2.0 million for Q1 2020.

• In Q1 2020, Change in Receivables fell 637.63% year-over-year to -$2.0 million; the TTM figure through Dec 2020 stood at -$2.0 million (down 702.41% YoY), while the FY2020 annual figure was -$2.0 million, down 702.41% from the prior year.
• Change in Receivables was -$2.0 million for Q1 2020 at Cogent Biosciences, down from $1.1 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.1 million in Q4 2019 to a low of -$2.0 million in Q1 2020.
• Historically, Change in Receivables has averaged -$71384.6 across 4 years, with a median of $217000.0 in 2018.
• The sharpest annual moves came in 2018 and 2020: Change in Receivables jumped 1980.49% in 2018, then tumbled 637.63% in 2020.
• A 4-year view of Change in Receivables shows it stood at -$681000.0 in 2017, then soared by 136.56% to $249000.0 in 2018, then soared by 349.8% to $1.1 million in 2019, then tumbled by 278.57% to -$2.0 million in 2020.
• The last three Change in Receivables figures came in at -$2.0 million (Q1 2020), $1.1 million (Q4 2019), and -$612000.0 (Q3 2019), per Business Quant data.